I-Mab
NASDAQ:IMAB
I-Mab
Cash from Financing Activities
I-Mab
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
I-Mab
NASDAQ:IMAB
|
Cash from Financing Activities
¥42.4m
|
CAGR 3-Years
-77%
|
CAGR 5-Years
-51%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Cash from Financing Activities
-¥448.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Cash from Financing Activities
¥2.9B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Cash from Financing Activities
-¥893.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-98%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Cash from Financing Activities
-¥2.4B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-39%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Cash from Financing Activities
-¥374.2m
|
CAGR 3-Years
-104%
|
CAGR 5-Years
-98%
|
CAGR 10-Years
N/A
|
See Also
What is I-Mab's Cash from Financing Activities?
Cash from Financing Activities
42.4m
CNY
Based on the financial report for Dec 31, 2023, I-Mab's Cash from Financing Activities amounts to 42.4m CNY.
What is I-Mab's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-51%
Over the last year, the Cash from Financing Activities growth was 0%. The average annual Cash from Financing Activities growth rates for I-Mab have been -77% over the past three years , -51% over the past five years .